Citadel Advisors’s Kairos Pharma, Ltd. KAPA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,230	Closed	-$12.4K	–	7280
2025 Q1	$12.4K	Buy	13,230 +2,261	+21%	+$2.12K	﹤0.01%	5672
2024 Q4	$16.7K	Buy	+10,969	New	+$16.7K	﹤0.01%	5668